Recent studies indicated a high prevalence of hyperglycemia in non-diabetic patients presenting with acute coronary syndrome (ACS). However, the threshold of admission glucose (AG) as a predictor of adverse events in ACS is unclear

Al-Shboul, Qasim M.

Alawadi, Abdulhai

Garadah, Taysir S.

Kassab, Salah

Directory of Open Access Journals

PubMed Central

Clinical Medicine Insights Cardiology

English

Acute hyperglycemia: a new risk factor during myocardial infarction.

Acute myocardial infarction in patients treated for hypertension in Skaraborg hypertension Project. European heart Journal.

Admission blood glucose and adverse outcome in nondiabetic patients with myocardial infarction in the reperfusion era.

Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus.

Admission Glycemia and outcome after acute coronary syndrome.

Body Mass Index, a risk factor for unstable angina and myocardial infarction in patients with angiographically Conﬁ rmed Coronary Artery Disease.

Diabetes and stress hyperglycemia associated with myocardial infarction at an urban municipal hospital: prevalence and effect on mortality. Cardiol Rev.

Elevated glycosylated haemoglobin in non-diabetic patients is associated with an increased mortality in myocardial infarction.

Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study.

Hildebrandt PR (OPTIMAAL Study group). Unrecognized glycometabolic disturbance as measured by hemoglobin A1C is associated with a poor outcome after acute myocardial infarction.

Hyperglycemia and cardiovascular events. Dtsch Med Chenschr.

Hyperglycemia and Cardiovascular events. Dtsch Med wochenschr.

Hyperglycemia in relation to sex and mortality after acute coronary syndrome. Eur J cardiovasc Prev rehabil.

Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and ﬁ brin clot resistance to lysis in patients with acute coronary syndrome. Diabetes care.

Hyperglycemia: still an important predictor of adverse outcomes following AMI in the reperfusion era. Diabetes Res.

Impaired glucose metabolism predicts mortality after a myocardial infarction. Am heart J.

Impaired glucose metabolism predicts mortality after myocardial infarction.

Importance of a history for the prognosis after acute myocardial infarction: for the bucindolol evaluation in acute myocardial infarction (BEAT) study group. Clinical Cardiology.

insulin and myocardial ischaemia. Curr opin Clin Nutr Metab Care.

Insulin: an endogenous cardio-protector. Current Opin Crit Care.

Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?

Ischemic preconditioning protection against stunning in conscious diabetic sheep: role of glucose, insulin, sarcolemmal and mitochondrial LATP channels. Cardiovasc Res.

Predictors of acute myocardial infarction mortality in hypertensive patients treated in primary care, A population-based follow up study in the Skaraborg project.

Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes.

Prognostic value of admission glucose in non-diabetic patients with myocardial infarction.

Prognostic value of admission plasm glucose and HBA in acute myocardial infarction. Diabet Med.

Stress hyperglycemia and increased risk of death after myocardial infarction in patient with and without diabetes: a systemic review.

Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between

The association between hyperglycemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes Diabet.

Third report of the National Cholesterol Education Program (NECP) Expert Panel on detection, evaluation, and treatment of the high blood cholesterol in adult (adult treatment panel III) Circulation.

TNFα-induced insulin resistance in vivo and its prevention by troglitazone.

Yudkin JS: Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction. Br Heart J.

The Threshold of Admission Glycemia as a Predictor of Adverse Events in Diabetic and Non-Diabetic Patients with Acute Coronary Syndrome